🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Belgium / NCT05414045
Recruiting Not applicable

Autologous Testicular Tissue Transplantation

NCT05414045 · tracked via the Priya Life Science Belgium tracker
Phase
Not applicable
Started
2024-11-22
Last updated
2026-04-23

Condition(s) studied

CancerSickle Cell ThalassemiaHematologic Diseases

Investigational drug(s) / intervention(s)

Autologous testicular tissue transplantation of prepubertal frozen testicular tissue

Autologous testicular tissue transplantation of prepubertal frozen testicular tissue: Freezing testicular tissue of prepubertal boys is a method for preserving spermatogonial stem cells. If no spermatozoa suitable for ICSI are detected in the ejaculate, the investigators will perform autologous testicular tissue transplantation with the primary objective being to restore spermatogenesis and fertility.

Study summary

Freezing testicular tissue of prepubertal boys is a method for preserving spermatogonial stem cells in case of imminent gonadotoxic treatment during childhood. In case of total azoospermia or absence of spermatozoa that can be used for intra-cytoplasmic injection (ICSI) in adulthood, the investigators intend to perform the first in men autologous testicular tissue transplantation to restore fertility.

Eligibility

Sex
MALE
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
The eligible patients opted as a prepubertal boy to enroll in the fertility preservation program and on the moment of cancer diagnosis or hematological disorder, their parents have agreed to cryopreserve testicular tissue for later autologous transplantation. Inclusion Criteria: * At least 18 years old * In case of female partner, age \< 43 year * Absence of spermatozoa that can be used for ICSI on 2 semen analyses * Normal standardised preliminary and preoperative bloodsampling results * Complete remission of the oncological or hematological disease * Approval of the treating oncologist or other specialist in case of non-oncological disease as reason for the testicular tissue preservation as a child * Risk for presence of malignant cells in testicular tissue is negligible (according to multidisciplinary assessment) * Presence of spermatogonial stem cells (positive MAGE staining) in one or two of the thawed fragments (If absence of spermatogonial stem cells in two of the thawed fragments, the case will be discussed multidisciplinary) * Written informed consent for the transplantation of cryopreserved testicular tissue and follow-up after the procedure and of children born eventually after this procedure Exclusion criteria: * Risk for presence of malignant cells in the testicular tissue * Contra-indication for surgery * Contra-indication for pregnancy in the female partner * BMI \> 32 * Heavy smoking (≥10 cigarettes/day) * Instable psychological condition

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
UZ Brussel Centre for Reproductive Medicine Brussels Belgium Recruiting

More Universitair Ziekenhuis Brussel trials in Belgium

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05414045 on ClinicalTrials.gov ↗ ← All trials in Belgium